Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Magrolimab by Gilead Sciences for Oral Cavity (Mouth) Cancer: Likelihood of Approval
Magrolimab is under clinical development by Gilead Sciences and currently in Phase II for Oral Cavity (Mouth) Cancer. According to...
Magrolimab by Gilead Sciences for Oropharyngeal Cancer: Likelihood of Approval
Magrolimab is under clinical development by Gilead Sciences and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase...
Magrolimab by Gilead Sciences for Laryngeal Cancer: Likelihood of Approval
Magrolimab is under clinical development by Gilead Sciences and currently in Phase II for Laryngeal Cancer. According to GlobalData, Phase...
Magrolimab by Gilead Sciences for Hypopharyngeal Cancer: Likelihood of Approval
Magrolimab is under clinical development by Gilead Sciences and currently in Phase II for Hypopharyngeal Cancer. According to GlobalData, Phase...